Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Edan

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2017
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-upAnne Kerbrat, Benoit Combès, Olivier Commowick, et al.
Plos One|April 3, 2014
Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learningAlessandro Crimi, Olivier Commowick, Adil Maarouf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2012
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumabPer Soelberg Sørensen, Antonio Bertolotto, Gilles Edan, et al.
Journal of Neurology|May 10, 2024
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trialLudwig Kappos, Gilles Edan, Mark S Freedman, et al.
Lancet (London, England)|July 3, 2015
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trialEmmanuelle Le Page, David Veillard, David A Laplaud, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 4, 2018
Co-occurrence of MS and ALS: a clue in favor of common pathophysiological findings?Anne-Marie Guennoc, Maud Pallix-Guyot, Emmanuelle Le Page, et al.
Xenotransplantation|September 3, 2003
The effect of mitoxantrone on anti-pig immunization in baboonsThomas Petzold, Nathalie Barreau, Joanna Ashton-Chess, et al.
Multiple Sclerosis and Related Disorders|July 31, 2022
Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective studyAlix Callens, Soline Leblanc, Emmanuelle Le Page, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practiceLaura Couloume, Laetitia Barbin, Emmanuelle Leray, et al.
European Journal of Human Genetics : EJHG|January 22, 2009
IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patientsNicolas Couturier, Pierre-Antoine Gourraud, Isabelle Cournu-Rebeix, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2017
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-upAnne Kerbrat, Benoit Combès, Olivier Commowick, et al.
Plos One|April 3, 2014
Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learningAlessandro Crimi, Olivier Commowick, Adil Maarouf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2012
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumabPer Soelberg Sørensen, Antonio Bertolotto, Gilles Edan, et al.
Journal of Neurology|May 10, 2024
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trialLudwig Kappos, Gilles Edan, Mark S Freedman, et al.
Lancet (London, England)|July 3, 2015
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trialEmmanuelle Le Page, David Veillard, David A Laplaud, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 4, 2018
Co-occurrence of MS and ALS: a clue in favor of common pathophysiological findings?Anne-Marie Guennoc, Maud Pallix-Guyot, Emmanuelle Le Page, et al.
Xenotransplantation|September 3, 2003
The effect of mitoxantrone on anti-pig immunization in baboonsThomas Petzold, Nathalie Barreau, Joanna Ashton-Chess, et al.
Multiple Sclerosis and Related Disorders|July 31, 2022
Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective studyAlix Callens, Soline Leblanc, Emmanuelle Le Page, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 18, 2019
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practiceLaura Couloume, Laetitia Barbin, Emmanuelle Leray, et al.
European Journal of Human Genetics : EJHG|January 22, 2009
IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patientsNicolas Couturier, Pierre-Antoine Gourraud, Isabelle Cournu-Rebeix, et al.
Pageof 15